|
Powered by Cell Signaling Technology |
Site Information |
---|
LGGYSAGrGIYSRYH SwissProt Entrez-Gene |
Blast this site against: NCBI SwissProt PDB |
Site Group ID: 9480259 |
In vivo Characterization | |
---|---|
Methods used to characterize site in vivo: | |
Relevant cell line - cell type - tissue: |
References | |
---|---|
Guo A, et al. (2014) Immunoaffinity enrichment and mass spectrometry analysis of protein methylation. Mol Cell Proteomics 13, 372-87
24129315 Curated Info |
|
Mulhern D (2012) CST Curation Set: 15845; Year: 2012; Biosample/Treatment: tissue, embryo/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info |
|
Mulhern D (2012) CST Curation Set: 15846; Year: 2012; Biosample/Treatment: tissue, embryo/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info |
|
Guo A (2012) CST Curation Set: 14308; Year: 2012; Biosample/Treatment: tissue, embryo/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info |
|
Guo A (2012) CST Curation Set: 14309; Year: 2012; Biosample/Treatment: tissue, embryo/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info |
|
Guo A (2012) CST Curation Set: 14312; Year: 2012; Biosample/Treatment: tissue, embryo/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info |
|
Guo A (2012) CST Curation Set: 14313; Year: 2012; Biosample/Treatment: tissue, embryo/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info |
|
Zhou J (2009) CST Curation Set: 6540; Year: 2009; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info |
|
Zhou J (2009) CST Curation Set: 6534; Year: 2009; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info |
|
Zhou J (2009) CST Curation Set: 6533; Year: 2009; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info |
|
Zhou J (2009) CST Curation Set: 6020; Year: 2009; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info |
|
Zhou J (2009) CST Curation Set: 6017; Year: 2009; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info |
|
Zhou J (2009) CST Curation Set: 6024; Year: 2009; Biosample/Treatment: cell line, MEF/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: mR
Curated Info |